Faculty Invited Speaker in International Conferences

01.

Bajraktari G. Dual Antiplatelet Therapy and Current Approach. 37th National Congress of Turkish Society of Cardiology. Antalya, Turkey. Noveber 17-21, 2021.

02.

Bajraktari G. Management of HF in patients with chronic ischemic heart disease. 22nd Annual International Congress of the Egyptian Heart Failure Working Group. Cairo, Egypt. October 21-22, 2021.

03.

Bajraktari G. The Value of New Echo Techniques in Heart Failure. 21st Annual International Congress of the Egyptian Heart Failure Working Group. Cairo, Egypt. October 29-31, 2020.

04.

Bajraktari G. Clinical and echocardiographic features in diabetic and non-diabetic patients with chronic HF. 47th Annual Congress of the EgSC “CardioEgypt 2020”. Cairo, Egypt. February 24-27, 2020.

05.

Bajraktari G. How did myocardial revascularisation guidelines change our routine clinical practice. VIIIth National Congress of the Azerbayan Society of Cardiology. Baku, Azerbaijan. November 29-December 1, 2019.

06.

Bajraktari G. Elimination of Disparities in Central-Eastern Europe – A viewpoint from Kosovo. Annual Scientific Congress of the Hungarian Society of Cardiology. Balataonfured, Hungary. May 3-5, 2019.

07.

Bajraktari G. Exercise Hypertension. XXVI Congress of the Hungarian Society of Hypertension. Balataonfured, Hungary. September 20-22, 2018.

08.

Bajraktari G. Challenges and Successes of Cardiology Care in Kosovo. Annual Scientific Congress of the Hungarian Society of Cardiology. Balataonfured, Hungary. May 11-13, 2018.

09.

Bajraktari G. Determinants of exercise capacity in HFpEF and HFrEF. Annual Congress of the Prevention Association of European Society of Cardiology – EuroPrevent 2018. Ljubljana, Slovenia. April 19-21, 2018.

10.

Bajraktari G. Implementation of ISACS- TC in Kosovo. Working Group of Coronary Pathophysiology and Microcircualtion of the ESC. Bologna, Italy. February 19-20, 2018.

11.

Bajraktari G. Elective non-cardiac surgery in patients with dual antiplatelet therapy. XXI Nationl Conference of Albanian Society of Cardiology. Tirana, Albania. December 16, 2017.

12.

Bajraktari G. Controversies in the treatment patients with STEMI and multivessel disease. 33rd Turkish Cardiology Congress with International Participation. Antalya, Turkey; 5-8 October, 2017.

13.

Bajraktari G. Treatment of multivessel CAD in diabetes – with focus on microcirculation. First European Joint Meeting: WG 6 and the Council of Hypertension. Sinaia, Romania; 17-18 February 2017.

14.

Bajraktari G. Left Atrium as a predicror in HF patients. 11th Congress of Croatian Cardiac Society. Zagreb, Croatia; 3-6 November, 2016

15.

Bajraktari G. Actual treatment of cardiovascular disease in Kosovo. 7th Congress of Cardiologist and Angiologists of Bosnia and Herzegovina. Rimini, Italia; 2-4 June, 2016.

16.

Bajraktari G. PCI in STEMI: culprit artery vs. complete revascularisation. 7th Congress of Cardiologist and Angiologists of Bosnia and Herzegovina. Mostar, Bosnia and Herzegovina; 26-28 May, 2016.

17.

Bajraktari G. Heart Failure with Preserved Ejection Fraction: Diagnosis & Treatment. XIX Nationl Conference of Albanian Society of Cardiology. Tirana, Albania. December 19, 2015.

18.

Bajraktari G. Exercise capacity in HFpEF patients. XXI World Congress of Echocardiography and Cardiology. Istanbul, Turkey. November 20-22, 2015.

19.

Bajraktari G. Assessment of diastolic function. EuroEcho-Imaging 2014. Vienna, Austria; December 3-6, 2014.

20.

Bajraktari G. Implantable cardioverter-defibrilator indications for ventricular arrhythmias in 2014.EuroEcho-Imaging 2014. Vienna, Austria; December 3-6, 2014.

21.

Bajraktari G. Echocardiographic predictors in aortic stenosis patients. The XIXth World Congress of Echocardiography and allied Techniques. Sibiu, Romania; May 9-12, 2014.

22.

Bajraktari G. Coronary Artery Disease. 2nd International Congress of Biomedical Sciences. Tirana, Albania; May 1-3, 2014.

23.

Bajraktari G. Echo predictors in aortic stenosis. 7th Croatian Echocardiography Meeting with International Participation. Dubrovnik, Croatia; May 23-25, 2013.

24.

Bajraktari G. Should We Operate Asymptomatic Patients with Severe Aortic Stenosis? 8th International Congress of Update in Cardiology and Cardiovascular Surgery. Anatalya, Turkey; March 1-4, 2012.

25.

Bajraktari G. Should we operate asymptomatic patients with severe mitral regurgitation? 3rd Conference of Albanian Society of Echocardiography. Tirana, Albania; October 8, 2011.

26.

Bajraktari G. Treatment strategies in patients with advanced heart failure. 7th Annual Congress of the Turkic World Cardiology. Istanbul, Turkey; October 21-24, 2010

27.

Bajraktari G. LV twist in aortic stenosis with preserved ejection fraction. 26th International Conference on Recent Advances in Echocardiography and Allied Techniques. Atlanta, Georgia, USA; March 13th, 2010.

28.

Bajraktari G. Ischaemic mitral regurgitation: How to assess the severity? Should these patients be referred to surgery 2nd Conference of Albanian Society of Echocardiography. Tirana, Albania; November 17, 2009.

29.

Bajraktari G. MRSA endocarditis in Contegra bovine conduite. 25th International Conference on Recent Advances in Echocardiography and Allied Techniques. Orlando, Florida, USA. March 28, 2009.

30.

Bajraktari G. Echocardiography predictors in heart failure patients. Third Croatian Echocardiography Symposium with International Participation, Opatija, Croatia; October 16-18, 2009.

31.

Bajraktari G. Metabolic syndrome – inflammatory theory. XII Conference of Albanian Society of Cardiology. Tirana, Albania; December 7th, 2008.

32.

Bajraktari G. Left ventricular long axis function. 1st conference of Albanian Society of Echocardiography. Tirana, Albania; October 20th, 2007.

33.

Bajraktari G. Echocardiographic assessment of left ventricular long axis function. Second Croatian Symposium of Echocardiography (with international participation). Opatija, Croatia; October 11-13, 2007.

34.

Bajraktari G. Echocardiography in Diabetics. XIth World Congress of Echocardiography and Vascular Ultrasound & the 1st International Congress on Hypertension. Rodos, Greece; June 29th – July 1st, 2007.

35.

Bajraktari G. The Prognostic Role of Total Isovolumic Time in Patients with Coronary Artery Disease. X World Congress Of Echocardiography And Cardiovascular Imaging. Rome, Italy; October 19-21, 2006.

36.

Bajraktari G. Echocardiographic evaluation of the mitral regurgitation in daily practice. International teaching course on echocardiography: Valvular heart diseases – State of the art. Tirana, Albania; 14 October 2006.

37.

Bajraktari G. Mitral valve Endocarditis: How to distinguish vegetations from other abnormalities. 2nd Annual Congress on Cardiology and Cardiac Surgery. Bodrum, Turkey; 20-24 September, 2006.

38.

Bajraktari G. The prognostic role of total isovolumic time in patients with coronary artery disease. 14th Alpe Adria Cardiology Meeting. Cavtat-Dubrovnik, Croatia; 3-7 May, 2006.

39.

Bajraktari G. The diastolic dysfunction in diabetic patients-role of Doppler echocardiography. International Meeting on Echocardiography. Tirana, Albania; 24 September 2005.

40.

Bajraktari G, New Methods for the assessment of left ventricular function by echocardiography. 16 th Annual Meeting of Mediterranean Association of Cardiology and Cardiac Surgery. Bodrum, Turkey; 26-30 September, 2004.

41.

Bajraktari G. Primary and secondary prevention by statins. 43rd Romanian Congress of Cardiology. Poiana Brasov, Romania; 15-18 September 2004.

42.

Bajraktari G. The role of echocardiography in early detecting of diastolic dysfunction in diabetic patients. 3 rd Congress of Cardiologist and Angiologists of Bosnia and Herzegovina. Tuzla, Bosnia and Herzegovina; 27-30 May, 2004

43.

Bajraktari G. The role of TEE in mitral stenosis. VIII. World Congress of Echocardiography and Vascular Ultrasound. Antalya, Turkey; 6-9 May, 2004

44.

Bajraktari G. The role of echocardiography in early detecting of diastolic dysfunction in diabetic patients. VIII World Congress of Echocardiography and Vascular Ultrasound. Antalya, Turkey; 6-9 May, 2004.

45.

Bajraktari G. The role of diastolic dysfunction screening in NIDDM patients. 1st International Symposium on Echocardiography. Ohrid, Macedonia; 14-16 September, 2003.